AUCTORES
Globalize your Research
Research Article | DOI: https://doi.org/10.31579/2637-8892/185
Department of Psychiatry, Azerbaijan Medical University, Azerbaijan
*Corresponding Author: Karimova Rumiyya Zakariyya, Department of Psychiatry, Azerbaijan Medical University, Azerbaijan
Citation: Karimova Rumiyya Zakariyya (2022) Antipsychotics Use in Vascular Dementia. J Psychology and Mental Health Care, 6(5): DOI: 10.31579/2637-8892/185
Copyright: © 2022, Karimova Rumiyya Zakariyya, This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited
Received: 02 September 2022 | Accepted: 06 September 2022 | Published: 23 September 2022
Keywords: vascular dementia; psychotic symptoms; delusions; hallucinations; neuroleptics
Background: In the clinic of dementia, not only cognitive, but also non-cognitive disorders are observed. In the treatment of these symptoms, the use of antipsychotics is necessary. As the etiology and pathogenesis of vascular dementia, which is a type of dementia, is multifactorial, it requires more careful treatment while treating with antipsychotics.
Material and methods: The aim of the research was to study the effectiveness of neuroleptics used in the treatment of psychotic disorders in vascular dementia. A Mini-Mental State Examination (MMSI) scale and Neuropsychiatric Inventory (NPI) were completed for each patient 4 weeks before and after treatment. The dose was reduced when side effects were observed during the study.
Result: The mean score on the NPI scale was 58.7 ± 2.0 (23-106), and in the 4th week of treatment it dropped to 13.9 ± 1.8 (0-64). In other words, a decrease of 76.3% was recorded in the total scores. If the decrease between pre- and post-treatment scores on the NPI scale was more than 30%, it was considered that there was a positive dynamics in the course of symptoms, and neuroleptics were effective
Conclusions: The study showed that neuroleptics can be prescribed to patients with vascular dementia. But at the same time, basic conditions must be observed. Treatment should begin with a low dose and gradually increase the dose over the first 4 weeks.
Dementia is a disorder of the upper cortex as a result of chronic and progressive disease of the brain. As the other types of dementia, the main symptom of vascular dementia is cognitive impairment. In many cases, along with cognitive decline, non-cognitive symptoms are also observed. Although the main focus and treatment is against cognitive decline, it is the non-cognitive symptoms that bother patients and their caregivers. The frequency of non-cognitive impairments in different types of dementia is also different [1-3,5, 7,13,14]. In vascular dementia, One psychopathological symptom is observed in 81.1 Percent of cases, and 2 or more symptoms are observed in 15 Percent of cases. There were reports of apathy in 56.6 Percent anxiety and agitation in 18.9 Percent delusions in 14-27 Percent, hallucinations in 5-14 Percent, depression and disinhibition in 5.6 Percent. of patients [9-12]. However, in any case, caregivers of these patients are more concerned about psychopathological symptoms than the decline in cognitive function. Psychiatrists are often consulted for these symptoms.
Basic therapy for vascular dementia both prevents and affects the development of psychotic disorders. Sometimes such psychotic symptoms can develop and worsen against the background of basic therapy [8]. To date, the use of neuroleptics is not recommended due to the etiology and pathogenesis of dementia [6]. Randomized placebo studies were not able to prove the effect of antipsychotics on behavior and psychotic symptoms. Thus, in the meta-analysis of 15 randomized studies and in the meta-analysis of 42 placebo-controlled studies, many neuroleptics were compared, and it was found that discontinuation of treatment was more common because the expected effect was not achieved [8]. Unfortunately, most of these studies were performed on patients with other types of dementia. More research is needed to investigate the use of neuroleptics in vascular dementia. Despite the relative effectiveness of neuroleptics in the treatment of behavioral problems and mental disorders in vascular dementia, we face serious safety shortcomings. Taking neuroleptics in itself increases the risk of cardiovascular complications (stroke, heart attack, lethal outcome). Also, in patients receiving neuroleptics, prolonged QT interval on the ECG, decreased cognitive function, decreased daily activity due to sedation and extrapyramidal effects, difficulty in care and deaths are observed [4]. However, in many cases, given the severity of psychotic and behavioral disorders, the use of neuroleptics is necessary by comparing risk and benefit.
To assess the effectiveness and safety of antipsychotics for the treatment of psychosis in people with vascular dementia
The study was conducted at the Republican Psychiatric Hospital of the Ministry of Health of the Republic of Azerbaijan in 2019-2022. The study included patients who had been treated for "vascular dementia with psychotic disorders" over the years. Patients with mild dementia and various degrees of psychotic disorders were selected according to the requirements of the study. Patients with other types of dementia who had vascular dementia and no psychotic sympathy were not included in the study. On the recommendation of the Azerbaijan Ethics Committee patients with previous diagnoses of schizophrenia, schizoaffective disorder, delirium, bipolar disorder, cognitive decline after Intracranial injury, persistent delirium, and other types of dementia were also excluded from the study.
All patients included in the study were examined by a therapist and a neurologist and, if necessary, referred to a cardiologist, endocrinologist and surgeon. A Mini-Mental State Examination scale (MMSE; Folstein et al., 1975) and Neuropsychiatric Inventory (NPI; Cummings JL et al., 1994) were completed for each patient before and 4 weeks after. The dose was reduced when side effects were observed during the study. When side effects did not end and the patient was disturbed, he/she was excluded from the study with the patient's consent. The decision to continue treatment and research during the study was voluntary by the patient and his / her relatives. He/she was excluded from the study at their request. The data were statistically processed to objectively evaluate all the data obtained. Statistical analyss were undertaken using the SPSS statistical software version 23. Descriptive statistics were presented as mean values and stantdard deviation or percentages, according to the nature of the variable. The level of statistical significance was set at p Less than0.005.
77 patients participated in the study. All patients were diagnosed with vascular dementia (F01.x4 ) according to ICD-10 criteria. Their mean age was 72.3 ± 0.9 (57-91). The average score of patients on the MMSI (Mini-Mental State Examination) scale was 20.4 ± 0.4. The NPI scale (NPI; Cummings JL et al., 1994) covered 12 symptoms. These included: delusions, hallucinations, aggression / agitation, depression / dysphoria, anxiety, euphoria, apathy, disinhibition (impulsive and thoughtless actions), lability, aberrant / motor behavior, sleep and nightime behavior disorders, appetite and eating disorders. First of all, it was clarified whether there were any symptoms in the last 4 weeks. If the answer was positive, the frequency of symptoms, the degree of expression, the degree of distress were evaluated [2,15-29]. Prior to treatment, the mean score on the NPI scale was 58.7 ± 2.0 (23-106), and in the 4th week of treatment it dropped to 13.9 ± 1.8 (0-64). In other words, a decrease of 76.3 Percent was recorded in the total scores. If the decrease between pre- and post-treatment scores on the NPI scale was more than 30 Percent, it was considered that there was a positive dynamics in the course of symptoms, and neuroleptics were effective. Based on this rule, the degree of expression, degree of distress and frequency of occurrence of each symptom were calculated separately. In order to more clearly observe the effectiveness of neuroleptics, it was assumed that the change in scores had a treatment effect if it was more than 30 Percent, and that the treatment effect was small if it was less than 30 Percent. Cases of no change in scores were also investigated. We think that such a conditional separation allows us to draw more accurate conclusions (Table 1 and 2).
Table 1. Dynamics of scores on NPI
Table 2. Dynamics of symptoms on the NPI scale
The side effects of neuroleptics were also studied for 4 weeks. Side effects were observed in 31 (40.3%) patients. In 46 (59.7%) patients, no side effects were observed during the first 4 weeks with the minimum dose of neuroleptics. Side effects observed during treatment were: parkinsonism,
muscle weakness, hypotension, convulsions, urination, drowsiness, gait changes (Table 3). Only 8 out of 77 patients refused treatment due to side effects. The results of the treatment are presented in the table below (Table 4 ). (Table 7).
Table 3. Side effects observed in patients
Table 4. Outcome of treatment of psychotic symptoms observed in vascular dementia.
These result showed that, during the first 4 weeks of treatment with neuroleptics, irritability, agitation/aggression, sleep and night time behavior disorders respond better. Based on the results, we can say that apathy is the least effective symptom of the neuroleptics used for treatment. The effect of neuroleptics on delusions and hallucinations is almost the same. However, antipsychotics are effective to varying degrees in the treatment of all non-cognitive symptoms, Since p Less than 0.001 is for all symptoms according to statistical calculations, smaller doses have fewer side effects, resulting in fewer treatment discontinuations. It is advisable to keep the dose as small as possible even during the first 4 weeks. This will both reduce the development of side effects that can lead to treatment
rejection and reduce mortality. We can say that neuroleptics have an effect in the treatment of non-cognitive symptoms. In many cases it is necessary to use neuroleptics by evaluating the phase of harm and benefit.
Antipsychotics are not recommended for patients with vascular dementia. However, in many cases it is necessary to use neuroleptics by measuring the phase of harm and benefit. In this case, it is recommended to start with a small dose and gradually increase the dose. This will both reduce the development of side effects that can lead to treatment rejection and reduce mortality.
This study has some limitations. Despite the obvious limitation of this study due to the small number of samples, we can argue that it shows promising data.
The article carried out by own financial resource.
Author declare that the manuscript is submitted on behalf of all author. None of the material in this manuscript has been published previously in any form and none of the material is currently under consideration for publication elsewhere other than noted in the cover letter to the editor. Author declare to have any financial and personal relationship with other people or organizations that could inappropriately influence this work. Author contributed to and have approved the final manuscript.
Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.
Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.
Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.
Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.
We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.
The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.
Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.
Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.
Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.
Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.
Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.
This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.
Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.
As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.
Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.
International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.
Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.
Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.
I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!
"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".
I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.
We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.
I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.
I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.
I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.
Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.
“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.
Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao.
Clinical Cardiology and Cardiovascular Interventions I testity the covering of the peer review process, support from the editorial office, and quality of the journal.
